Sentence examples for feasibility of circulating from inspiring English sources

We have demonstrated the feasibility of circulating miRs as biomarkers in this patient group and proposed specific candidates that warrant further evaluation for potential clinical use.

However, despite the fact that several published papers demonstrated the feasibility of using circulating miRNAs as putative cancer biomarkers, many preanalytical and analytical aspects, as well as donor-related factors, can interfere with accurate circulating miRNA quantification, and future studies have to take them into consideration.

To investigate the feasibility of detecting circulating cancer cells in peripheral blood from gastric cancer patients using Piwi-interacting RNAs (piRNAs) as markers.

While change of H5 HA specificity is experimentally possible, the propensity for the requisite mutations to occur in vivo depends on the feasibility of the circulating strains of H5N1 virus acquiring the necessary nucleotide changes.

Independent studies have reported the feasibility of using circulating miRNAs as promising disease biomarkers and, in the context of malignancies, they have shown a potential as molecular tools for detection, prognosis, and treatment decision making of various cancers [ 17– 23].

As the authors' primary aim was to evaluate the feasibility of using circulating miRNAs for detection and staging of breast cancer, it would have been prudent to obtain blood samples pre-operatively.

Additionally, we will evaluate the feasibility of using circulating tumor DNA and miRNA profiles in plasma, to monitor tumor response to TNT, in rectal cancer patients treated in both of the protocol arms.

Here, we evaluated the T2DM-related miRNA signature in plasma of three study groups: normal (fasting glucose (FG), 4.8 5.2 mmol/L), T2DM-susceptible (FG, 6.1 6.9 mmol/L), and T2DM individuals (FG, ≥7.0 mmol/L) and tested the feasibility of using circulating miRNAs to identify individuals at risk of developing T2DM.

In the current study, we evaluated the feasibility and clinical utility of circulating miRNAs as biomarkers for the detection and staging of breast cancer.

In this study, we evaluated the plasma expression patterns of five T2DM-related miRNAs in three study groups: normal individuals (fast glucose (FG), 4.8 5.2 mmol/L), T2DM susceptible individuals (FG, 6.1 6.9 mmol/L) and diagnosed T2DM patients (FG, ≥7.0 mmol/L), and tested the feasibility of clinical application of circulating miRNAs in early prediction of T2DM in susceptible individuals.

It has been shown that tumor-associated circulating miRs (miR-10b, miR-34a, miR-141, and miR-155) are elevated in the blood of breast cancer patients, and hence there would be feasibility and clinical utility of circulating miRNAs as biomarkers for the detection and staging of breast cancer [ 49].